Catabasis Pharmaceuticals CEO Jill Milne's 2019 pay slips 9% to $1M
Catabasis Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Catabasis Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at Catabasis Pharmaceuticals received on average a compensation package of $793K, a 11% decrease compared to previous year.
Average pay of disclosed executives at Catabasis Pharmaceuticals
Jill C. Milne, Chief Executive Officer, received $1M in total, which decreased by 9% compared to 2018. 48% of Milne's compensation, or $501K, was in salary. Milne also received $232K in bonus, $298K in option awards, as well as $2K in other compensation.
Joanne M. Donovan, Chief Medical Officer, received a compensation package of $714K, which decreased by 14% compared to previous year. 59% of the compensation package, or $424K, was in salary.
Andrew Nichols, Chief Scientific Officer, earned $632K in 2019, a 12% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2020.